Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast

Annals of Internal Medicine

Volumn 133, Issue 12, 2000, Pages 964-968

  Reinus, J F ^a   Persky, S ^a   Burkiewicz, J S ^a   Quan, D ^a   Bass, N M ^a   Davern, T J ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLPREDNISOLONE; MONTELUKAST; PREDNISONE; SALBUTAMOL; SALBUTAMOL SULFATE; SALMETEROL XINAFOATE; STEROID; THEOPHYLLINE; ZAFIRLUKAST;

ADULT; ARTICLE; ASTHMA; CASE REPORT; CHRONIC SINUSITIS; DRUG INDUCED DISEASE; FEMALE; HUMAN; LIVER INJURY; LIVER TRANSPLANTATION; PRIORITY JOURNAL; STEROID THERAPY; TOXIC HEPATITIS;

EID: 0034687835     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-133-12-200012190-00011     Document Type: Article

References (12)

1. New approaches to anti-inflammatory therapy for asthma
2. New perspectives for asthma treatment: Antileukotriene drugs
3. Treatment of asthma with drugs modifying the leukotriene pathway
4. Summary of clinical trials with zafirlukast
5. Zafirlukast for symptomatic mild-to-moderate asthma: A 13-week multicenter study
6. Liver disease caused by drugs, anesthetics, and toxins
7. Leukotriene modifiers and Churg-Strauss syndrome: Adverse effect or response to corticosteroid withdrawal
8. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients
9. Acute liver failure associated with prolonged use of bromfenac leading to liver transplantation